Imeik Technology Development's (SHE:300896) attributable profit rose 16% to 1.12 billion yuan in the first half from 963.4 million yuan in the year-ago period, according to a Thursday filing with the Shenzhen Stock Exchange.
Earnings per share at the Chinese biomedical products manufacturer decreased 16% to 3.72 yuan from 4.45 yuan in the previous year.
Operating income grew 14% to 1.66 billion yuan from 1.46 billion yuan a year earlier.
Shares plunged 10% during Thursday's morning trading.
Price (RMB): ¥147.57, Change: ¥-17, Percent Change: -10.06%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments